Jundishapur Journal of Microbiology

Published by: Kowsar

Analysis of DNA gyrA Gene Mutation in Clinical and Environmental Ciprofloxacin-Resistant Isolates of Non-Tuberculous Mycobacteria Using Molecular Methods

Bahram Nasr Esfahani 1 , Fatemeh Sadat Zarkesh Esfahani 2 , * , Nima Bahador 2 , Sharareh Moghim 1 , Tooba Radaei 1 , Hadi Rezaei Yazdi 3 , Hajiyeh Ghasemian Safaei 1 and Hossein Fazeli 1
Authors Information
1 Department of Microbiology, Isfahan University of Medical Sciences, Isfahan, IR Iran
2 Department of Microbiology, Science and Research Branch, Islamic Azad University, Fars, IR Iran
3 Department of Microbiology, Jahrom University of Medical Sciences, Jahrom, IR Iran
Article information
  • Jundishapur Journal of Microbiology: March 01, 2016, 9 (3); e30018
  • Published Online: March 11, 2016
  • Article Type: Research Article
  • Received: June 19, 2015
  • Revised: October 20, 2015
  • Accepted: December 22, 2015
  • DOI: 10.5812/jjm.30018

To Cite: Nasr Esfahani B, Zarkesh Esfahani F S, Bahador N, Moghim S, Radaei T, et al. Analysis of DNA gyrA Gene Mutation in Clinical and Environmental Ciprofloxacin-Resistant Isolates of Non-Tuberculous Mycobacteria Using Molecular Methods, Jundishapur J Microbiol. 2016 ; 9(3):e30018. doi: 10.5812/jjm.30018.

Abstract
Copyright © 2016, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Neonakis IK, Gitti Z, Krambovitis E, Spandidos DA. Molecular diagnostic tools in mycobacteriology. J Microbiol Methods. 2008; 75(1): 1-11[DOI][PubMed]
  • 2. Doucet-Populaire F, Buriankova K, Weiser J, Pernodet JL. Natural and acquired macrolide resistance in mycobacteria. Curr Drug Targets Infect Disord. 2002; 2(4): 355-70[PubMed]
  • 3. Luong A, McClay JE, Jafri HS, Brown O. Antibiotic therapy for nontuberculous mycobacterial cervicofacial lymphadenitis. Laryngoscope. 2005; 115(10): 1746-51[DOI][PubMed]
  • 4. Collins CH, Yates MD, Uttley AH. Differentiation of Mycobacterium chelonei from M. fortuitum by ciprofloxacin susceptibility. J Hyg (Lond). 1985; 95(3): 619-21[PubMed]
  • 5. Gay JD, DeYoung DR, Roberts GD. In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii. Antimicrob Agents Chemother. 1984; 26(1): 94-6[PubMed]
  • 6. Drlica K, Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev. 1997; 61(3): 377-92[PubMed]
  • 7. Morris S, Bai GH, Suffys P, Portillo-Gomez L, Fairchok M, Rouse D. Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J Infect Dis. 1995; 171(4): 954-60[PubMed]
  • 8. Snider Jr DE, Roper WL. The new tuberculosis. N Engl J Med. 1992; 326(10): 703-5[DOI][PubMed]
  • 9. Iseman MD. Treatment of multidrug-resistant tuberculosis. N Engl J Med. 1993; 329(11): 784-91[DOI][PubMed]
  • 10. Parashar D, Das R, Chauhan DS, Sharma VD, Lavania M, Yadav VS, et al. Identification of environmental mycobacteria isolated from Agra, north India by conventional & molecular approaches. Indian J Med Res. 2009; 129(4): 424-31[PubMed]
  • 11. Nasr Esfahani B, Rezaei Yazdi H, Moghim S, Ghasemian Safaei H, Zarkesh Esfahani H. Rapid and accurate identification of Mycobacterium tuberculosis complex and common non-tuberculous mycobacteria by multiplex real-time PCR targeting different housekeeping genes. Curr Microbiol. 2012; 65(5): 493-9[DOI][PubMed]
  • 12. Krishnan MY, Manning EJ, Collins MT. Comparison of three methods for susceptibility testing of Mycobacterium avium subsp. paratuberculosis to 11 antimicrobial drugs. J Antimicrob Chemother. 2009; 64(2): 310-6[DOI][PubMed]
  • 13. Guillemin I, Cambau E, Jarlier V. Sequences of conserved region in the A subunit of DNA gyrase from nine species of the genus Mycobacterium: phylogenetic analysis and implication for intrinsic susceptibility to quinolones. Antimicrob Agents Chemother. 1995; 39(9): 2145-9[PubMed]
  • 14. Guillemin I, Jarlier V, Cambau E. Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria. Antimicrob Agents Chemother. 1998; 42(8): 2084-8[PubMed]
  • 15. Dauendorffer JN, Guillemin I, Aubry A, Truffot-Pernot C, Sougakoff W, Jarlier V, et al. Identification of mycobacterial species by PCR sequencing of quinolone resistance-determining regions of DNA gyrase genes. J Clin Microbiol. 2003; 41(3): 1311-5[PubMed]
  • 16. Isfahani BN, Tavakoli A, Salehi M, Tazhibi M. Detection of rifampin resistance patterns in Mycobacterium tuberculosis strains isolated in Iran by polymerase chain reaction-single-strand conformation polymorphism and direct sequencing methods. Mem Inst Oswaldo Cruz. 2006; 101(6): 597-602[PubMed]
  • 17. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007; 175(4): 367-416[DOI][PubMed]
  • 18. Falkinham 3rd JO. Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev. 1996; 9(2): 177-215[PubMed]
  • 19. Mokaddas E, Ahmad S. Development and evaluation of a multiplex PCR for rapid detection and differentiation of Mycobacterium tuberculosis complex members from non-tuberculous mycobacteria. Jpn J Infect Dis. 2007; 60(2-3): 140-4[PubMed]
  • 20. Klemen H, Bogiatzis A, Ghalibafian M, Popper HH. Multiplex polymerase chain reaction for rapid detection of atypical mycobacteria and Mycobacterium tuberculosis complex. Diagn Mol Pathol. 1998; 7(6): 310-6[PubMed]
  • 21. Vacher S, Pellegrin JL, Leblanc F, Fourche J, Maugein J. Comparative antimycobacterial activities of ofloxacin, ciprofloxacin and grepafloxacin. J Antimicrob Chemother. 1999; 44(5): 647-52[PubMed]
  • 22. Gayathri R, Therese KL, Deepa P, Mangai S, Madhavan HN. Antibiotic susceptibility pattern of rapidly growing mycobacteria. J Postgrad Med. 2010; 56(2): 76-8[DOI][PubMed]
  • 23. Sanchez-Carrillo C, Cotarelo M, Cercenado E, Vicente T, Blazquez R, Bouza E. Comparative in-vitro activity of sparfloxacin and eight other antimicrobial agents against clinical isolates of non-tuberculous mycobacteria. J Antimicrob Chemother. 1996; 37(1): 151-4[PubMed]
  • 24. Rafi A, Moaddab SR, Radmehr R. Drug resistance study of Mycobacterium tuberculosis strains and mycobacteria other than tubercle bacilli strains to ofloxacin and ciprofloxacin isolated from patients admitted to research center for TB and pulmonary diseases of Tabriz. Pharm Sci. 2009; 15(3): 241-6
  • 25. Hopewell R, Oram M, Briesewitz R, Fisher LM. DNA cloning and organization of the Staphylococcus aureus gyrA and gyrB genes: close homology among gyrase proteins and implications for 4-quinolone action and resistance. J Bacteriol. 1990; 172(6): 3481-4[PubMed]
  • 26. Yoshida H, Bogaki M, Nakamura M, Nakamura S. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother. 1990; 34(6): 1271-2[PubMed]
  • 27. Cambau E, Jarlier V. Resistance to quinolones in mycobacteria. Res Microbiol. 1996; 147(1): 52-9
  • 28. Kocagoz T, Hackbarth CJ, Unsal I, Rosenberg EY, Nikaido H, Chambers HF. Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra. Antimicrob Agents Chemother. 1996; 40(8): 1768-74[PubMed]
  • 29. Pitaksajjakul P, Worakhunpiset S, Chaiprasert A, Boonyasopun J, Ramasoota P. gyrA and gyrB mutations in ofloxacin-resistant Mycobacterium tuberculosis clinical isolates in Thailand. Southeast Asian J Trop Med Public Health. 2011; 42(5): 1163-7[PubMed]
  • 30. Pitaksajjakul P, Wongwit W, Punprasit W, Eampokalap B, Peacock S, Ramasoota P. Mutations in the gyrA and gyrB genes of fluoroquinolone-resistant Mycobacterium tuberculosis from TB patients in Thailand. Southeast Asian J Trop Med Public Health. 2005; 36 Suppl 4: 228-37[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments